Haldol 50 mg inyectable

An encephalopathic syndrome (characterized by weakness, lethargy , fever, tremulousness and confusion, extrapyramidal symptoms, leukocytosis , elevated serum enzymes, BUN , and fasting blood sugar) followed by irreversible brain damage has occurred in a few patients treated with lithium plus HALDOL. A causal relationship between these events and the concomitant administration of lithium and HALDOL has not been established; however, patients receiving such combined therapy should be monitored closely for early evidence of neurological toxicity and treatment discontinued promptly if such signs appear.

Haldol 50 mg inyectable

haldol 50 mg inyectable


haldol 50 mg inyectablehaldol 50 mg inyectablehaldol 50 mg inyectablehaldol 50 mg inyectable